Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1993-10-01
1995-11-28
Lacey, David L.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
5303881, 4241451, 4241581, 4351722, 43524027, A61K 39395, C07K 1636, C07K 1618
Patent
active
054709571
ABSTRACT:
Novel immunoinhibitors are capable of inhibiting thrombin-activated function of Factor XIII by binding to Factor XIII at a site other than the thrombin-cleavage site of Factor XIII.
REFERENCES:
Fukue et al., A Unique Factor XIII Inhibitor to a Fibrin-Binding Site on Factor XIIIA, Blood 79:65-74, 1992.
Gailani, An IgG Inhibitor Against Coagulation Factor XIII: Resolution of Bleeding after Plasma Immunoadsorption with Staphylococcal Protein A, Am. J. Medicine 92:110-112, 1992.
Galfre et al., Antibodies to Major Histocompatibility Antigens Produced by Hybrid Cell Lines, Nature 266:550-552, 1977.
Godal and Ly, An Inhibitor of Activated Factor XIII, Inhibiting Fibrin Cross-Linking but not Incorporation of Amine into Casin, Scand. J. Haemotol. 19:443-448, 1977.
Godal, An Inhibitor of Fibrin Stabilizing Factor (FSF, Factor XIII), Scand. J. Haemtol. 7:43-48, 1970.
Greenberg et al., Regulation of Thrombin Cleavage of Plasma Factor XIII Bound to Fibrin, Annals of The New York Academy of Sciences 485:140-143.
Janus et al., Promotion of Thrombin-Catalyzed Activation of Factor XIII by Fibrinogen, Biochemistry 27:6269-6272, 1983.
Krumdieck et al., Hemorrhagic Disorder Due to an Isoniazid-Associated Acquired Factor XIII inhibitor in a Patient with Waldenstrom's Macrogloblulinemia, Am. J. Medicine 90:639-645, 1991.
Lewis et al., An Acquired Inhibitor to Coagulation Factor XIII, The Johns Hopkins Medical Journal 120:401-407, 1967.
Lopaciuk et al., Differences Between Type I Autoimmune Inhibitors of Fibrin Stabilization in Two Patients with Servere Hemorrhagic Disorder, J. Clin. Invest. 61:1196-1203, 1978.
Lorand et al., Autoimmune Antibody (IgG Kansas) Against the Fibrin Stablizing Factor (Factor XIII) System, Proc. Natl. Acad. Sci. USA 85:232-236, 1988.
Lorand et al., A Filter Paper Assay for Transamidating Enzymes Using Radioactive Amine, Substrates, Analytical Biochemistry 50:623-631, 1972.
Lukacova and Reed, Single Step Purification of Platelet Factor XIII Using an Immobulized Factor XIII A-Subunit Monoclonal Antibody, Thrombosis and Haemostasis 69:397-400, 1993.
Lukacova et al., Inhibition of Factor XIII Activation by an Anti-Peptide Monoclonal Antibody, Biochemistry 30:10164-10170, 1991.
Lukacova et al., Functional Characteristics of a Monoclonal Antibody Directed to the Thrombin Activation Site of Factor XIII, FASEB J. 5:A515 (Abstract #837), 1991.
Lynch et al., Monoclonal Antibodies to Factor XIII, Thrombosis and Haemostasis 54:274 (Abstract #01627) 1985.
McDevitt et al., An Acquired Inhibitor to Factor XIII, Arch. Intern Med 130:772-777, 1972.
Milner et al., Practolol Therapy Associated with a Systemic Lupus Erythematosus-Like Syndrome and an Inhibitor to Factor XIII, J. Clin. Path. 30:770-773, 1977.
Nakamura et al., Bleeding Tendency Caused by IgG Inhibitor to Factor XIII, Treated Successfully by Cyclophosphamide, British J. Haematology 68:313-319, 1988.
Naski et al., Characterization of the Kinetic Pathway for Fibrin Promotion of .alpha.-Thrombin-Catalyzed Activation of Plasma Factor XIII, Biochemistry 30:934-941, 1991.
Otis et al., An Acquired Inhibitor of Fibrin Stabilization Associated with Isoniazid Therapy: Clinical and Biochemical Observations, Blood 44:771-781, 1974.
Reed et al., Synergistic Fibinolysis: Combined Effects of Plasminogen Activators and an Antibody that Inhibits .alpha.2-antiplasmin, Proc. Natl. Acad. Sci. USA 87:1114-1118, 1990.
Rosenberg et al., A New Haemorrhagic Disorder with Defective Fibrin Stabilization and Cryofibrinogenaemia, British Journal of Haematology 26269-284, 1974.
Sakata and Aoki, Cross-Linking of .alpha.2-Plasmin Inhibitor to Fibrin by Fibrin-stablizing Factor, J. Clin. Invest. 65:290-297, 1980.
Schlaeger and Schumpp, Propagation of a Mouse Myeloma Cell Line J558L Producing Human CD4 Immunoglobulin G1, J. Immunological Methods 146111-120, 1992.
Shebuski et al., Inhibition of Factor XIIIa in a Canine Model of Coronary Thrombosis: Effect on Reperfusion and Acute Reocclusion After Recombinant Tissue-Type Plasminogen Activator, Blood 75:1455-1459, 1990.
Gambel Phillip
Lacey David L.
President and Fellows of Harvard College
The General Hospital Corporation
LandOfFree
Immunoinhibitors of factor XIII does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunoinhibitors of factor XIII, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunoinhibitors of factor XIII will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2014579